Skip to content

IMDX IMDX Return on equity

Return on equity at other companies

CareDx logo
CareDxCDNA
-2.4%-21.9pp
Guardant Health logo
Guardant HealthGH
-438.1%-1,655pp
Natera, Inc. logo
Natera, Inc.NTRA
-29%+4.1pp
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
-6.8%+48.2pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
2.5%+1.3pp
Agilent Technologies logo
Agilent TechnologiesA
21.3%+2.4pp

Other financials

Income statement

See full
Revenue$32.0K-98.5%
Gross profit$15.0K-98.9%
Operating income-$4.4M+35.1%
Net income-$4.3M+35.7%
EPS (diluted)-$0.12+53.8%

Balance sheet

See full
Cash & equivalents$28.2M-9.1%
Total debt$2.9M-13.5%
Total equity-$10.7M-205%
Total assets$40.4M-33.0%

Cash flow

See full
Operating cash flow-$7.6M-30.8%
CapEx$613.0K+99.7%
Free cash flow-$8.3M-34.3%

Valuation

See full
Market cap$185.35M+92.3%
Enterprise value$160.03M+113%
P/S95.1×+72.5×

Profitability

See full
Gross margin51.3%-3.0pp
Operating margin-2,500.7%+4,459pp
Net margin-2,454.6%+4,017pp
FCF margin-1,409.7%-6,023pp

Returns & leverage

See full
Debt / equity2.9×+2.8×
Current ratio2.5×-1.2×

Where this comes from

Calculated from IMDX’s reported figures.

Based on trailing twelve months.

The official record: IMDX’s 10-Q, filed August 11, 2025, on SEC EDGAR. View the filing →

Ask your AI about IMDX's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IMDX's return on equity?
IMDX (IMDX) reported return on equity of -532.9% in Q2 2025.
How has IMDX's return on equity changed year-over-year?
IMDX's return on equity decreased by 388.8% year-over-year, from -109% to -532.9%.
What is the long-term trend for IMDX's return on equity?
Over 3 years (2020 to 2023), IMDX's return on equity has grown at a 2.9% compound annual growth rate (CAGR), from -93.1% to -101.5%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.